GLP-1 Side Effect Language Patients Use

A living wiki page for fatigue, nausea, GI symptoms, mood, and other patient-described GLP-1 experience signals.

Last updated: 2026-05-26. This page is generated from the PulseGLP second brain and should be treated as market-intelligence context, not medical or legal advice.

Current Signal Snapshot

• 3,188 matching patient-evidence rows in the last 180 days.
• 487 matching Meta ad observations in the last 180 days.
• 0 matching FDA warning-letter findings in the enforcement corpus.
• Newest matching patient evidence was observed 5/22/2026.
• Newest matching ad observation was seen 5/22/2026.

Patient Evidence Patterns

• Top drug/entity mix in sampled evidence: Retatrutide (13), Zepbound (8), Wegovy (5), GLP-1 (4), Tirzepatide (3), Semaglutide (2).
• Highest-volume sampled sources: r/Retatrutide (13), r/Zepbound (8), r/WegovyWeightLoss (5), r/GLP1 (4), r/Tirzepatide (3), r/Semaglutide (2).
• Classification mix in sampled evidence: Risk-Alert (20), Positive (8), Analytical (5), Neutral-Low (3).
• Use Ask Pulse to inspect source-level citations before turning this signal into campaign copy, clinical workflow changes, or compliance guidance.

FDA And Compliance Context

• PulseGLP tracks potential FDA-cited language patterns; it does not determine whether a claim is compliant or non-compliant.

Ad Market Signals

• Advertisers appearing in the sampled matching set: Beyond the Scale (8), Sarah Mitchell (3), American Health Report (1), Bioma.Health (1), Grewal Law PLLC (1), Menopause & Wellness Daily (1).
• Creative Intelligence can inspect the underlying ads for risk-level labels, themes, landing URLs, and repeated positioning patterns.
• Ad counts reflect observed library rows and can include deduped or updated observations from recovered collection runs.

How Ask Pulse Uses This Page

• Ask Pulse retrieves this page as durable context before it looks at fresh raw evidence.
• The page helps keep answers consistent across repeated questions about the same topic.
• Raw evidence citations are still required for specific factual claims or patient-language details.

Related PulseGLP Wiki Pages

• No high-signal rows are available yet.